Forvis Wealth Advisors, LLC Astrazeneca PLC Transaction History
Forvis Wealth Advisors, LLC
- $4.26 Billion
- Q3 2024
A detailed history of Forvis Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 3,056 shares of AZN stock, worth $200,565. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,056
Previous 3,171
3.63%
Holding current value
$200,565
Previous $247,000
3.64%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...